Literature DB >> 25093465

Cytokine expression in human osteoblasts after antiseptic treatment: a comparative study between polyhexanide and chlorhexidine.

Eric Röhner1, Paula Hoff, Timo Gaber, Annemarie Lang, Pauline Vörös, Frank Buttgereit, Carsten Perka, Christoph Windisch, Georg Matziolis.   

Abstract

PURPOSE/AIM OF THE STUDY: Chlorhexidine and polyhexanide are frequently used antiseptics in clinical practice and have a broad antimicrobial range. Both antiseptics are helpful medical agents for septic wound treatment with a high potential for defeating joint infections. Their effect on human osteoblasts has, so far, not been sufficiently evaluated. The aim of this study was to investigate the activating potential of polyhexanide and chlorhexidine on inflammatory cytokines/chemokines in human osteoblasts in vitro.
MATERIALS AND METHODS: Human osteoblasts were isolated and cultivated in vitro and then treated separately with 0.1% and 2% chlorhexidine and 0.04% polyhexanide as commonly applied concentrations in clinical practice. Detection of cell structure and cell morphology was performed by light microscopic inspection. Cytokine and chemokine secretion was determined by using a multiplex suspension array.
RESULTS: Cell shrinking, defective cell membrane, and the loss of cell adhesion indicated cell damage of human osteoblasts after treatment with both antiseptics was evaluated by using light microscopy. Polyhexanide, but not chlorhexidine, caused human osteoblasts to secrete various interleukins (1β, 6, and 7), interferon γ, tumor necrosis factor α, vascular endothelial growth factor, eotaxin, fibroblast growth factor basic, and granulocyte macrophage colony-stimulating factor as quantified by multiplex suspension array.
CONCLUSIONS: Both antiseptics induced morphological cell damage at an optimum exposure between 1 and 10 min. But only polyhexanide mediated a pronounced secretion of inflammatory cytokines and chemokines in human osteoblasts. Therefore, we recommend a preferred usage of chlorhexidine in septic surgery to avoid the induction of an inflammatory reaction.

Entities:  

Keywords:  chemokines; chlorhexidine; cytokines; human osteoblasts; polyhexanide

Mesh:

Substances:

Year:  2014        PMID: 25093465     DOI: 10.3109/08941939.2014.941445

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  6 in total

1.  Evaluation of angiogenesis, epithelialisation and microcirculation after application of polyhexanide, chitosan and sodium chloride in rodents.

Authors:  Ole Goertz; Henrik Lauer; Tobias Hirsch; Adrien Daigeler; Kamran Harati; Ingo Stricker; Marcus Lehnhardt; Leon von der Lohe
Journal:  Int Wound J       Date:  2015-03-10       Impact factor: 3.315

2.  Mesenchymal stromal cell and osteoblast responses to oxidized titanium surfaces pre-treated with λ = 808 nm GaAlAs diode laser or chlorhexidine: in vitro study.

Authors:  Flaminia Chellini; Marco Giannelli; Alessia Tani; Lara Ballerini; Larissa Vallone; Daniele Nosi; Sandra Zecchi-Orlandini; Chiara Sassoli
Journal:  Lasers Med Sci       Date:  2017-05-27       Impact factor: 3.161

3.  An in vitro comparison of antimicrobial efficacy and cytotoxicity between povidone-iodine and chlorhexidine for treating clinical endometritis in dairy cows.

Authors:  Natcha Thongrueang; Shyh-Shyan Liu; Huan-Yu Hsu; Hsu-Hsun Lee
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

Review 4.  Is Chlorhexidine in Dentistry an Ally or a Foe? A Narrative Review.

Authors:  Łukasz Pałka; Agnieszka Nowakowska-Toporowska; Bartosz Dalewski
Journal:  Healthcare (Basel)       Date:  2022-04-20

5.  The Effect of Different Irrigation Solutions on the Cytotoxicity and Recovery Potential of Human Osteoblast Cells In Vitro.

Authors:  Jacob F Markel; Therese Bou-Akl; Paula Dietz; Alan M Afsari
Journal:  Arthroplast Today       Date:  2021-01-19

6.  Cytotoxic effect of sodium hypochlorite (Lavanox 0.08%) and chlorhexidine gluconate (Irrisept 0.05%) on human osteoblasts.

Authors:  Sabrina Böhle; Eric Röhner; Timo Zippelius; Benjamin Jacob; Georg Matziolis; Sebastian Rohe
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.